NCT06658171 Effects of Relaxation Training and Stimulus Control in Chronic Insomnia Patients
| NCT ID | NCT06658171 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Chronic Insomnia |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to validate the effect of relaxation training and stimulus control on reducing hyperarousal states and improving maladaptive sleep behaviors.
Eligibility Criteria
Inclusion Criteria: 1. Meet the diagnostic criteria for insomnia disorder according to DSM-5. 2. Pittsburgh Sleep Quality Index (PSQI) total score \> 5. 3. Age ≥ 18 years, with at least a middle school education level. 4. Anxiety symptoms meeting HAMA ≥ 14. 5. "Self-developed 8-item questionnaire on maladaptive sleep behaviors" used to assess "maladaptive sleep behaviors." 6. Voluntarily participate in this study and sign an informed consent form. Exclusion Criteria: 1. Individuals with severe physical illnesses or severe mental disorders, at risk of suicide. 2. Clinically diagnosed or suspected sleep-related breathing disorders, restless leg syndrome, and sleep-wake rhythm disorders, as well as shift workers. 3. Pregnant or lactating women. 4. Currently undergoing any psychological therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06658171 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06658171 currently recruiting?
Yes, NCT06658171 is actively recruiting participants. Contact the research team at wanghongxing@xwh.ccmu.edu.cn for enrollment information.
Where is the NCT06658171 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06658171 clinical trial?
NCT06658171 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 88 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.